Somnomed Ltd
ASX:SOM

Watchlist Manager
Somnomed Ltd Logo
Somnomed Ltd
ASX:SOM
Watchlist
Price: 0.785 AUD -1.88% Market Closed
Market Cap: 171.3m AUD

Wall Street
Price Targets

SOM Price Targets Summary
Somnomed Ltd

Wall Street analysts forecast SOM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SOM is 1.015 AUD with a low forecast of 1 AUD and a high forecast of 1.05 AUD.

Lowest
Price Target
1 AUD
27% Upside
Average
Price Target
1.015 AUD
29% Upside
Highest
Price Target
1.05 AUD
34% Upside
Somnomed Ltd Competitors:
Price Targets
ACARIX
Acarix AB
35% Upside
IRTC
iRhythm Technologies Inc
31% Upside
6669
Acotec Scientific Holdings Ltd
0% Downside
853
Microport Scientific Corp
46% Upside
LUCD
Lucid Diagnostics Inc
236% Upside
2190
Zylox-Tonbridge Medical Technology Co Ltd
42% Upside
CREO
Creo Medical Group PLC
293% Upside
NVST
Envista Holdings Corp
2% Upside

Revenue
Forecast

Revenue Estimate
Somnomed Ltd

For the last 13 years the compound annual growth rate for Somnomed Ltd's revenue is 16%. The projected CAGR for the next 3 years is 9%.

16%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Somnomed Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Somnomed Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-59%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SOM's stock price target?
Price Target
1.015 AUD

According to Wall Street analysts, the average 1-year price target for SOM is 1.015 AUD with a low forecast of 1 AUD and a high forecast of 1.05 AUD.

What is Somnomed Ltd's Revenue forecast?
Projected CAGR
9%

For the last 13 years the compound annual growth rate for Somnomed Ltd's revenue is 16%. The projected CAGR for the next 3 years is 9%.

Back to Top